| pubmed-article:8616940 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8616940 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
| pubmed-article:8616940 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
| pubmed-article:8616940 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:8616940 | lifeskim:mentions | umls-concept:C0456389 | lld:lifeskim |
| pubmed-article:8616940 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:8616940 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
| pubmed-article:8616940 | lifeskim:mentions | umls-concept:C2926735 | lld:lifeskim |
| pubmed-article:8616940 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8616940 | pubmed:dateCreated | 1996-6-10 | lld:pubmed |
| pubmed-article:8616940 | pubmed:abstractText | Myocardial salvage is most likely to occur when thrombolytic therapy is administered within 4 to 6 hours of the onset of symptoms of myocardial infarction. The impact of delays within this early time period on final myocardial infarct size are unknown. The purpose of this study was to quantitate the relation between final myocardial infarct size and duration of symptoms before initiation of thrombolytic therapy in patients treated within 6 hours of symptom onset. | lld:pubmed |
| pubmed-article:8616940 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8616940 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8616940 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8616940 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8616940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8616940 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8616940 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8616940 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8616940 | pubmed:issn | 0009-7322 | lld:pubmed |
| pubmed-article:8616940 | pubmed:author | pubmed-author:WagnerG SGS | lld:pubmed |
| pubmed-article:8616940 | pubmed:author | pubmed-author:SelvesterR... | lld:pubmed |
| pubmed-article:8616940 | pubmed:author | pubmed-author:WeaverW DWD | lld:pubmed |
| pubmed-article:8616940 | pubmed:author | pubmed-author:CerqueiraM... | lld:pubmed |
| pubmed-article:8616940 | pubmed:author | pubmed-author:MaynardCC | lld:pubmed |
| pubmed-article:8616940 | pubmed:author | pubmed-author:RaittM HMH | lld:pubmed |
| pubmed-article:8616940 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8616940 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:8616940 | pubmed:volume | 93 | lld:pubmed |
| pubmed-article:8616940 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8616940 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8616940 | pubmed:pagination | 48-53 | lld:pubmed |
| pubmed-article:8616940 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:meshHeading | pubmed-meshheading:8616940-... | lld:pubmed |
| pubmed-article:8616940 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8616940 | pubmed:articleTitle | Relation between symptom duration before thrombolytic therapy and final myocardial infarct size. | lld:pubmed |
| pubmed-article:8616940 | pubmed:affiliation | University of Washington, Seattle, USA. | lld:pubmed |
| pubmed-article:8616940 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8616940 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8616940 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8616940 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8616940 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8616940 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8616940 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8616940 | lld:pubmed |
